The role of contrast enhanced ct plus pan-immune-inflammation value in predicting outcomes of hepatocellular carcinoma after hepatectomy

Lu He, Chunhong Hu

Open source

DOI
10.1080/14796694.2026.2735738
Published
2026-09-21
Container
Future Oncology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2735738,
  title = {The role of contrast enhanced ct plus pan-immune-inflammation value in predicting outcomes of hepatocellular carcinoma after hepatectomy},
  author = {Lu He and Chunhong Hu},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2735738},
  url = {https://doi.org/10.1080/14796694.2026.2735738}
}

RIS

TY  - JOUR
TI  - The role of contrast enhanced ct plus pan-immune-inflammation value in predicting outcomes of hepatocellular carcinoma after hepatectomy
AU  - Lu He
AU  - Chunhong Hu
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2735738
UR  - https://doi.org/10.1080/14796694.2026.2735738
ER  - 

APA

He, L., & Hu, C. (2026). The role of contrast enhanced ct plus pan-immune-inflammation value in predicting outcomes of hepatocellular carcinoma after hepatectomy. Future Oncology. https://doi.org/10.1080/14796694.2026.2735738

Source records